PERTINENT FINDINGS:18F-DPA-714 PET provided complementary information to 18F-FET PET on glioma heterogeneity, allowed the imaging of immune cell dynamics, supported the assessment of brain target engagement, and elucidated CSF-1R inhibition–induced effects in vivo. The gene discussed is CSF1R; the disease is central nervous system cancer.